Life360 Reports Record Q4 and FY 2024 ResultsMonthly Active Users Reached Approximately 79.6 million Record Annual Global Net Additions to Paying Circles of 457 thousand - Reaching Nearly 2.3 millionTotal Quarterly Revenue Grew 33% Year-Over-Year to $115.5 million Annualized Monthly Revenue increased 34% Year-Over-Year to $367.6 millionAchieved Positive Net Income in Q4 and Record Positive Adjusted EBITDA of $45.5 million for the Year
Life360 Enhances Advertising Capabilities with Strategic Acquisition of Fantix’s AdTech AI PlatformAI Data Science platform will empower smarter, targeted advertising solutions while preserving privacy
ASE Expands its Chip Packaging and Testing Facility to Enable Next-Gen Applications
ASE has officially launched its fifth plant in Penang, which will significantly build on the company’s strong packaging and testing capabilities in the Bayan Lepas Free Industrial Zone. The new plant is part of a strategic expansion plan that will expand the floor space of ASE’s Malaysia facility from its current area of 1 million square feet to approximately 3.4 million square feet.
Alterity Therapeutics Raises A$40.0 million in Placement– Funds to be used primarily to advance development of ATH434 in Parkinsonian Disorders –
Life360 to Announce Q4 and Full Year 2024 Financial Results on February 27, 2025SAN FRANCISCO, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Life360, Inc. (Nasdaq: LIF; ASX: 360), the leading family safety and location services company, will release its financial results for the fourth quarter and full year ended December 31, 2024, on Thursday, February 27, 2025 (U.S. PT) / Friday, February 28, 2025 (AEDT).
Dotz Nano to Present at the Small Cap Growth Virtual Investor Conference February 6thCompany invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming MilestonesMELBOURNE, Australia and SAN FRANCISCO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today issued a letter to shareholders.
Baker Hughes Secures Liquefaction Equipment Order for Woodside Louisiana LNGHOUSTON and LONDON, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Baker Hughes (
NASDAQBKR), an energy technology company, announced Monday an order from Bechtel Energy Inc. (Bechtel) to supply gas technology equipment for two liquefaction plants with a total capacity of approximately 11 MTPA for Phase 1 of Woodside Energy Group Ltd’s (ASX: WDS; NYSE: WDS) (Woodside) Louisiana LNG development opportunity. The order marks a significant milestone as Woodside targets final investment decision (FID) readiness from the first quarter of 2025.
ASE’s Sustainability Efforts Receive International Recognition With a Ranking on the Dow Jones Sustainability Indices for the Ninth Year in a Row
ASE Technology Holding Co., Ltd. (ASE, TAIEX: 3711, NYSE: ASX), the leading provider of semiconductor packaging, test, and system assembly services, today announced that it has been recognized for its remarkable ESG performance with an inclusion on the 2024 Dow Jones Sustainability Indices (DJSI) World and Emerging Markets. The DJSI are float-adjusted market capitalization weighted indices that measure the performance of companies selected using environmental, social and governance (ESG) criteria. This year, 71 large cap companies were assessed in the Semiconductors and Semiconductor Equipment Industry Group for eligibility to be included on the 2024 DJSI World and only 8 including ASE successfully made the cut. This marks the ninth consecutive year that ASE has made the list.
American Rare Earths to Present at the Precious Metals & Critical Materials Virtual Investor Conference December 11thCompany invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
Small Cap Growth Virtual Investor Conference Agenda Announced for December 5thCompany Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
Alterity Therapeutics Appoints Abby Macnish Niven as Company SecretaryMELBOURNE, Australia and SAN FRANCISCO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), has announced the appointment of Abby Macnish Niven as Alterity’s Company Secretary following her appointment as Chief Financial Officer of Alterity. Ms Macnish Niven assumes the role of Company Secretary from Mr Phillip Hains effective on 18 November 2024.
Life360 Reports Record Q3 2024 ResultsMonthly Active Users Reached Approximately 76.9 million for the QuarterRecord Global Net Additions to Paying Circles of 159 thousand - Reaching Nearly 2.2 million TotalTotal Revenue Grew 18% Year-Over-Year to $92.9 million Annualized Monthly Revenue increased 30% Year-Over-Year to $336.2 millionRaising Outlook for 2024 Adjusted EBITDA
Alterity Therapeutics Announces Presentation on Tracking the Progression of Multiple System Atrophy at International SymposiumMELBOURNE, Australia and SAN FRANCISCO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced the presentation of data from Alterity’s Biomarkers of progression in Multiple System Atrophy (bioMUSE) natural history study at the 35th International Symposium on the Autonomic Nervous System.
ISE Labs Investment Secures the Establishment of New Site for Semiconductor Packaging and Test in Mexico
ISE Labs, Inc., a leading provider of semiconductor engineering services, today announced the acquisition of a significant parcel of land within Axis 2 Industrial Park, located in Tonalá, a city and municipality within the Guadalajara Metropolitan Area. This strategic land purchase demonstrates the company’s long-term commitment to the state of Jalisco and establishes a footprint for future expansion.
